Tuesday 15 October 2019 ,
Tuesday 15 October 2019 ,
Latest News
  • PM for speedy disposal of Abrar murder case
  • AL govt transforms country into a Digital Bangladesh: PM
  • Economists who study poverty win Nobel Prize
  • BCL expels Amit Saha over Abrar murder
  • 9 to die for killing businessman in Chattogram
  • BUET admission test held
  • Biman flight makes emergency landing at Dhaka airport
  • Journalist Dil Monowara Monu passes away
  • 2 ‘Neo JMB members’ held over Guliastan, Science lab attacks
9 October, 2019 12:28:00 PM
Print

Johnson & Johnson must pay $8 bn over drug side effect: jury

Independent Online/AFP
Johnson & Johnson must pay $8 bn over drug side effect: jury
Johnson & Johnson said it was "confident (the ruling) will be overturned," calling the $8bn jury award against it "grossly disproportionate"

A Pennsylvania jury ruled Tuesday that US pharmaceutical giant Johnson & Johnson must pay $8 billion in damages and interest for failing to warn that a psychiatric drug could cause breast growth in men.

Johnson & Johnson and its subsidiary Janssen Pharmaceuticals were blamed as plaintiff Nicholas Murray told the Philadelphia court that the drug Risperdal, prescribed to treat schizophrenia and bipolar disorder, had made him grow breasts.

The company challenged the ruling in a statement, calling the damages awarded "grossly disproportionate" with the initial award in the case of $680,000.

"The company is confident (the ruling) will be overturned," the statement said, and "will be immediately moving to set aside this excessive and unfounded verdict."

In the statement, Johnson & Johnson accused the court of preventing their defense team from presenting "key evidence" on Risperdal labeling.

The company is facing a series of complaints in state courts for failing to properly warn of Risperdal's side effects, including in Pennsylvania, California and Missouri.

Risperdal, approved for the treatment of adults by the US Food and Drug Administration in 1993, brought in some $737 million (672 million euros) in sales in 2018.

HM

Comments

Video
More Business Stories

Copyright © All right reserved.

Editor : M. Shamsur Rahman

Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Editor : M. Shamsur Rahman
Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Disclaimer & Privacy Policy
....................................................
About Us
....................................................
Contact Us
....................................................
Advertisement
....................................................
Subscription

Powered by : Frog Hosting